Please provide your email address to receive an email when new articles are posted on . New data published in JAMA indicate that continuous pulse oximetry monitoring is being used often in children ...
IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ:MASI) announced today FDA 510(k) clearance for the pediatric indication for O3™ regional oximetry with the O3 pediatric sensor. Regional oximetry, also ...
NEUCHATEL, Switzerland--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced the results of a study published in Pneumonia in which independent researchers in New Delhi, India, investigated the ...
Obstructive sleep apnea (OSA) is a common sleep disorder in the U.S. affecting tens of millions, with estimates ranging from ...
Pulse oximetry can be performed with disposable or reusable sensors, and hospitals and birthing centers must select the type of sensor that best meets the needs of their facility. 1 The SACHDNC ...
According to the WHO release, the use of pulse oximetry for anesthesia monitoring during surgery has been a standard of care in the developed world for over 20 years. The same safety practices are not ...
The Medical Devices Advisory Committee of the U.S. Food and Drug Administration (FDA) recently met to review the reported inaccuracy of pulse oximetry in patients with darker skin. The meeting ...
The FDA grants 510(k) clearance for the use of Masimo's (NASDAQ:MASI) O3 regional oximetry in pediatric patients. Regional oximetry is used in situations where peripheral pulse oximetry (a device is ...
A recent study by researchers at the University of Nottingham in the United Kingdom reinforced a growing body of knowledge that not all blood oxygenation measurement devices, particularly pulse ...
Another week, another disparity of care. In this case, it's attributable to a measure known to be flawed: pulse oximetry. Does the flaw lie solely in the tool – or how it is used? Let’s take a deeper ...
The longstanding problem of pulse oximeters providing less-accurate readings for people with dark skin tones got another look Friday from a panel of experts for the US Food and Drug Administration.
Acknowledging the disparity in pulse oximetry implicates a $2 billion industry that has faced stricter regulations in recent years in an attempt to address bias in the development and testing of these ...